Drugs of Abuse Testing Products (DATPs) are a diverse range of tools and methods used to detect the presence of illicit or legally prescribed drugs in biological samples (urine, blood, saliva, hair) or on surfaces.
The global Drugs of Abuse Testing Products market size is projected to grow from US$ 4793.4 million in 2023 to US$ 8098.8 million in 2030; it is expected to grow at a CAGR of 7.8% from 2024 to 2030.
This report presents a comprehensive overview, market shares, and growth opportunities of Drugs of Abuse Testing Products market by product type, application, key players and key regions and countries.
Key Features
This Insight Report provides a comprehensive analysis of the global Drugs of Abuse Testing Products landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity.
Segmentation by Type
- Drugs of Abuse Detection Reagents
- Drug Abuse Testing Equipments
Segmentation by Application
- Hospital
- Law Enforcement
- Drug Treatment Center
- Research Institute
- Others
Market by Region
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
Company's Coverage
- Abbott
- Thermo Fisher
- Roche
- Siemens Healthineers
- Wondfo Biotech
- Randox
- OraSure
- Drager
- Labcorp
- Beckman Coulter
- Bruker
- InTec
- Orient Gene
- Hangzhou Biotest
- Assure Tech
- Aotai Bio
Key Questions Addressed in this Report
Frequently Asked Questions
What is the USP of the report? expand_more
What are the key content of the report? expand_more
- Global Market Players
- Geopolitical regions
- Consumer Insights
- Technological advancement
- Historic and Future Analysis of the Market